In conclusion, p16Ink4A semi-quantitative immunohistochemical analysis is a reliable, reproducible, and cost-effective testing that can potentially be employed to improve the characterization of lung neoplasms, allowing a more accurate patient’s management. This evidence concerns the gene CDKN2A and Neoplasm of the lung.